iBio Grants Caliber License for Production of Antibodies Targeting Ebola
10 nov. 2014 08h31 HE
|
iBio, Inc.
NEWARK, DE--(Marketwired - Nov 10, 2014) - iBio, Inc. (NYSE MKT: IBIO) and Caliber Biotherapeutics LLC executed an agreement, effective today, for an emergency use license to the iBioLaunch™...
iBio Expands Exclusive Product Collaboration With Novici Biotech
22 oct. 2014 08h31 HE
|
iBio, Inc.
NEWARK, DE--(Marketwired - Oct 22, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, and Novici Biotech LLC...
iBio Responds to Inquiries About its Role in Emergency Response to Ebola Virus Disease Outbreak
16 oct. 2014 08h31 HE
|
iBio, Inc.
NEWARK, DE--(Marketwired - Oct 16, 2014) - iBio, Inc. (NYSE MKT: IBIO) today confirmed, in response to shareholder and media inquiries: (i) the applicability of its issued U.S. iBioLaunch™...
iBio Reports on Filing of 2014 Annual Report
03 oct. 2014 17h00 HE
|
iBio, Inc.
NEWARK, DE--(Marketwired - Oct 3, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced, as required...
Dr. Thomas A. Medsger Jr. Joins iBio Clinical Advisory Board
02 sept. 2014 08h31 HE
|
iBio, Inc.
NEWARK, DE--(Marketwired - Sep 2, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of biotechnology for developing and manufacturing plant-made pharmaceutical products, has appointed Thomas...
iBio Receives European Patent Allowances for Protein Expression Technology
28 août 2014 08h31 HE
|
iBio, Inc.
NEWARK, DE--(Marketwired - Aug 28, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, received notices of intention to...
iBio Enters Into $10 Million Common Stock Purchase Agreement With Aspire Capital
26 août 2014 08h31 HE
|
iBio, Inc.
NEWARK, DE--(Marketwired - Aug 26, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, today announced it has...
iBio Forms Marketing Collaboration With Kanematsu Chemicals Corporation to Target Japanese Market
14 août 2014 08h31 HE
|
iBio, Inc.
NEWARK, DE--(Marketwired - Aug 14, 2014) - iBio, Inc. (NYSE MKT: IBIO), and Kanematsu Chemicals Corporation, part of Kanematsu Corporation (TSE: 8020), have entered into a collaboration agreement...
iBio Appoints Another IPF Expert, Dr. J. Terrill Huggins, to Clinical Advisory Board
30 juil. 2014 08h31 HE
|
iBio, Inc.
NEWARK, DE--(Marketwired - Jul 30, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, has appointed J....
iBio Appoints Dr. Richard M. Silver to Clinical Advisory Board
21 juil. 2014 08h31 HE
|
iBio, Inc.
NEWARK, DE--(Marketwired - Jul 21, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, has appointed Richard...